DK0475291T3 - Fra kylling afledt biologisk aktivt peptid (kylling CNP) - Google Patents

Fra kylling afledt biologisk aktivt peptid (kylling CNP)

Info

Publication number: DK0475291T3
Authority: DK; Denmark
Prior art keywords: chicken; biologically active; cnp; active peptide; derived biologically
Prior art date: 1990-09-07

Application number

DK91115080T

Other languages

English (en)

Inventor

Hisayuki Matsuo

Kenji Kangawa

Naoto Minamino

Original Assignee

Hisayuki Matsuo

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-07

Filing date

1991-09-06

Publication date

1999-08-30

1991-09-06 Application filed by Hisayuki Matsuo, Suntory Ltd filed Critical Hisayuki Matsuo

1999-08-30 Application granted granted Critical

1999-08-30 Publication of DK0475291T3 publication Critical patent/DK0475291T3/da

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
241000287828 Gallus gallus Species 0.000 title abstract 2
101000796284 Gallus gallus C-type natriuretic peptide Proteins 0.000 title 1
238000000034 method Methods 0.000 abstract 2
210000004556 brain Anatomy 0.000 abstract 1
239000003153 chemical reaction reagent Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000010353 genetic engineering Methods 0.000 abstract 1
230000001452 natriuretic effect Effects 0.000 abstract 1
238000000746 purification Methods 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1
230000002541 vasodepressive effect Effects 0.000 abstract 1
239000003071 vasodilator agent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Hematology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Heart & Thoracic Surgery (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK91115080T 1990-09-07 1991-09-06 Fra kylling afledt biologisk aktivt peptid (kylling CNP) DK0475291T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2238293A JP2977158B2 (ja)	1990-09-07	1990-09-07	トリ由来新規生理活性ペプチド（ニワトリｃｎｐ）

Publications (1)

Publication Number	Publication Date
DK0475291T3 true DK0475291T3 (da)	1999-08-30

Family

ID=17028039

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91115080T DK0475291T3 (da)	1990-09-07	1991-09-06	Fra kylling afledt biologisk aktivt peptid (kylling CNP)

Country Status (8)

Country	Link
US (1)	US5338830A (da)
EP (1)	EP0475291B1 (da)
JP (1)	JP2977158B2 (da)
AT (1)	ATE175210T1 (da)
DE (1)	DE69130696T2 (da)
DK (1)	DK0475291T3 (da)
ES (1)	ES2127190T3 (da)
GR (1)	GR3029628T3 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0203172B8 (pt)	2001-09-28	2021-05-25	Nakao Kazuwa	composição farmacêutica para acondroplasia
WO2005094890A1 (ja)	2004-03-31	2005-10-13	Kazuwa Nakao	身長増加用組成物
ES2465141T3 (es)	2004-03-31	2014-06-05	Kazuwa Nakao	Remedio o medicamento preventivo para la artritis
CA2559228C (en)	2004-04-21	2016-06-21	Enobia Pharma Inc.	Bone delivery conjugates and method of using same to target proteins to bone
WO2012088608A1 (en)	2010-12-27	2012-07-05	Enobia Canada Limited Partnership	Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en)	2012-05-21	2018-08-21	Alexion Pharmaceuticsl, Inc.	Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
WO2016007873A1 (en)	2014-07-11	2016-01-14	The Regents Of The University Of Michigan	Compositions and methods for treating craniosynostosis
MX389350B (es)	2014-12-05	2025-03-19	Alexion Pharma Inc	Fosfatasas alcalinas recombinantes y usos de las mismas para el tratamiento de convulsiones.
JP6868561B2 (ja)	2015-01-28	2021-05-12	アレクシオンファーマシューティカルズ，インコーポレイテッド	アルカリホスファターゼ欠損を有する被験者を治療する方法
JP7253220B2 (ja) *	2015-07-31	2023-04-06	株式会社イギス	Ｃｎｐ環状ペプチド並びに該環状ペプチドを含む医薬品、外用剤および化粧料
CN108350440A (zh)	2015-08-17	2018-07-31	阿雷克森制药公司	碱性磷酸酯的制造
JP6868617B2 (ja)	2015-09-28	2021-05-12	アレクシオンファーマシューティカルズ，インコーポレイテッド	低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
JP2018533571A (ja)	2015-10-30	2018-11-15	アレクシオンファーマシューティカルズ，インコーポレイテッド	患者の頭蓋縫合早期癒合症を治療するための方法
WO2017155569A1 (en)	2016-03-08	2017-09-14	Alexion Pharmaceuticals, Inc.	Methods for treating hypophosphatasia in children
US10898549B2 (en)	2016-04-01	2021-01-26	Alexion Pharmaceuticals, Inc.	Methods for treating hypophosphatasia in adolescents and adults
JP7613826B2 (ja)	2016-04-01	2025-01-15	アレクシオンファーマシューティカルズ，インコーポレイテッド	アルカリホスファターゼによって筋力低下を治療すること
US10988744B2 (en)	2016-06-06	2021-04-27	Alexion Pharmaceuticals, Inc.	Method of producing alkaline phosphatase
EP3500289B1 (en)	2016-08-18	2024-10-09	Alexion Pharmaceuticals, Inc.	Asfotase alfa for use in treating tracheobronchomalacia
EP3600383A4 (en)	2017-03-31	2020-10-28	Alexion Pharmaceuticals, Inc.	METHODS OF TREATMENT OF HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS
US11913039B2 (en)	2018-03-30	2024-02-27	Alexion Pharmaceuticals, Inc.	Method for producing recombinant alkaline phosphatase
US12268733B2 (en)	2018-08-10	2025-04-08	Alexion Pharmaceuticals, Inc.	Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
CA3161266A1 (en)	2019-12-09	2021-06-17	Alexion Pharmaceuticals, Inc.	Alkaline phosphatase polypeptides and methods of use thereof
AU2021337652B2 (en)	2020-09-04	2025-01-30	Alexion Pharmaceuticals, Inc.	Methods for treating bone mineralization disorders
BR112023016048A2 (pt)	2021-02-12	2023-11-14	Alexion Pharma Inc	Polipeptídeos de fosfatase alcalina e métodos de uso dos mesmos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2544929B2 (ja) *	1987-06-17	1996-10-16	第一化学薬品株式会社	新規生理活性ペプチド
US5114923A (en) *	1988-05-31	1992-05-19	California Biotechnology Inc.	Recombinant techniques for production of novel natriuretic and vasodilator peptides

1990
- 1990-09-07 JP JP2238293A patent/JP2977158B2/ja not_active Expired - Fee Related
1991
- 1991-09-04 US US07/754,947 patent/US5338830A/en not_active Expired - Fee Related
- 1991-09-06 AT AT91115080T patent/ATE175210T1/de not_active IP Right Cessation
- 1991-09-06 DE DE69130696T patent/DE69130696T2/de not_active Expired - Fee Related
- 1991-09-06 ES ES91115080T patent/ES2127190T3/es not_active Expired - Lifetime
- 1991-09-06 DK DK91115080T patent/DK0475291T3/da active
- 1991-09-06 EP EP91115080A patent/EP0475291B1/en not_active Expired - Lifetime
1999
- 1999-03-09 GR GR990400718T patent/GR3029628T3/el unknown

Also Published As

Publication number	Publication date
GR3029628T3 (en)	1999-06-30
ATE175210T1 (de)	1999-01-15
DE69130696D1 (de)	1999-02-11
JP2977158B2 (ja)	1999-11-10
EP0475291B1 (en)	1998-12-30
EP0475291A1 (en)	1992-03-18
ES2127190T3 (es)	1999-04-16
JPH04120094A (ja)	1992-04-21
US5338830A (en)	1994-08-16
DE69130696T2 (de)	1999-06-10

Publication	Publication Date	Title
DK0475291T3 (da)	1999-08-30	Fra kylling afledt biologisk aktivt peptid (kylling CNP)
GR3029632T3 (en)	1999-06-30	A novel biologically active peptide derived from frog (frog CNP)
FI924453A0 (fi)	1992-10-02	Nya 9-amino-7-(substituerad)-6-demetyl-6-deoxitetracykliner
DE69020794D1 (de)	1995-08-17	Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
FI924454A0 (fi)	1992-10-02	Nya 7-substituerad-9-(substituerad amino)-6-demetyl-6-deoxitetracykliner
ATE87006T1 (de)	1993-04-15	Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE152734T1 (de)	1997-05-15	Bpc-peptide, deren herstellung und verwendung
NO895028D0 (no)	1989-12-14	Ny chimerisk transformerende vekstfaktor-beta.
ES2108016T3 (es)	1997-12-16	Triazolopiridazinas substituidas.
DK38889A (da)	1989-01-27	Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DE3689008D1 (de)	1993-10-21	Verfahren zur Herstellung und Reinigung von alpha-Interferon.
ATE47880T1 (de)	1989-11-15	Vorlaeufer eines an dem c-ende amidierten peptids und dessen herstellung.
ES2124694T3 (es)	1999-02-16	Clonacion de la n-metil-hidantoinasa.
ATE130630T1 (de)	1995-12-15	Sg(beta)-1,4-galaktanase und dns-sequenz.
ATE14126T1 (de)	1985-07-15	Verfahren zur herstellung von 2-acyl1,3,4,6,7,11b-2h-hexahydro-4-pyrazino(2,1a)isochinolinonen und zwischenprodukte.
ATE133709T1 (de)	1996-02-15	Peroxidase-gen von mikrobischem ursprung
ES2079054T3 (es)	1996-01-01	Peptidilhidroxiglicina n-c-liasa y adn codificante de la misma.
ATE116336T1 (de)	1995-01-15	Bakteriozin-peptid.
ES2059766T3 (es)	1994-11-16	Precursor de prostaglandinas y su produccion.
FR2551088B1 (da)	1985-12-06
ATE102997T1 (de)	1994-04-15	Thymosin und tnf-kodierende dna.
EP1295943A4 (en)	2005-11-16	POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES
ATE37865T1 (de)	1988-10-15	Verfahren zur herstellung von monochloressigsaeure aus glykolsaeure.
IT8423089A0 (it)	1984-10-10	Solubilizzazione di ossigeno mediante adsorbimento dell'ossigeno nei fanghi biologici degli impianti di depurazione a fanghi attivi.
SE8403252L (sv)	1985-12-19	Forfarande vid forbrenning, jemte brensle